| Name | Feedback |
|---|---|
| Epic | FDBK |
| Isin | GB00BJN59X09 |
| Industry | Medical Equipment and Services |
| Latest share price | 19.80p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £8.68 | Debt ratio | n/a |
| Shares in issue | 43.81 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -103.17 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -24.74 | 52-week high / low | 16.50p / 140.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Feedback |
|---|---|
| Address | 201 Temple Chambers 3-7 Temple Avenue, London, United Kingdom, EC4Y 0DT |
| Telephone | +44 (0) 1954 718072 |
| Website | http://www.fbk.com/ |
| Director | Position |
|---|---|
| Dr Tom Oakley | CEO |
| Mr Anesh Patel | CFO |
| Mr Adam Denning | Non-Executive Director |
| Ms Annemijn Eschauzier | Non-Executive Director |
| Professor Rory Shaw | Non-Executive Chairman |
| Mr Philipp Prince | Independent Non-Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/05/24 | 31/05/23 | 31/05/22 |
| Intangible asssets and goodwill | 4.07 | 3.71 | 3.29 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 4.08 | 3.73 | 3.3 |
| Inventory / work in progress | n/a | n/a | 0.31 |
| Trade and other receivables | 0.08 | 0.23 | n/a |
| Cash and equivalents | 3.88 | 7.32 | 10.31 |
| Other current assets and asset held for resale | 0.3 | 0.46 | 0.39 |
| Total of all assets | 8.34 | 11.72 | 14.3 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 0.69 | 0.86 | 0.59 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.69 | 0.86 | 0.59 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 7.64 | 10.87 | 13.71 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 6.67 | 6.67 | 6.67 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -15.07 | -11.77 | -8.85 |
| Share premium account | 15.35 | 15.35 | 15.35 |
| Total equity | 7.64 | 10.87 | 13.71 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.69 | -3.42 | -2.51 |
| Pre-tax profit | -3.6 | -3.37 | -2.51 |